Market, Sales and Customers

The market potential for minimally invasive sterilization devices is very large, with more than 800,000 sterilization procedures performed in the United States and over 15 million performed annually, world-wide. In the US and UK, 40% of couples over age 40 elect sterilization. This market is currently underserved and the medical community is gradually recognizing the opportunity for minimally invasive, hysteroscopic sterilization.

The total US Market for permanent sterilization was $3.0B in 2006, $2.6B of which was derived from laparoscopic tubal ligation procedures, today’s gold standard of care. New technologies requiring no-incisions, such as the ZRO device, are projected to capture market share in this large market.

The Company will market directly to women’s health providers, such as OB/GYNs, and to women, using various means such as direct sales, visits to doctor’s offices, patient web-site information, surgeon training, advertising/mailer campaigns and other traditional methods. This technology offers surgeons a great value proposition allowing them to capture more profits due to their ability to perform the surgery at their office or surgicenter and increase the number of procedures due to time savings.